Schedule 13D ownership disclosure

UNUM THERAPEUTICS INC

Security class unavailable · CUSIP: 903214104

Event date: 2020-07-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,482,460
Percent of class
19.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897069-20-000304
Form type
SC 13D
Filer
Fairmount Funds Management LLC
CIK
CIK 1802528
Filed
Jul 10, 2020
Reporting period
Jul 06, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub